Myriad Genetics | MYGN - Current Liabilities

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.97

Myriad Genetics reported $133.8M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Illumina USD 1.59B 377M Dec/2025
J&J USD 57.72B 3.59B Mar/2026
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Quidel USD 966.1M 198.2M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veracyte USD 59.94M 12.22M Dec/2025
Waters USD 1.24B 11.8M Dec/2025